A NEW APPROACH TO TREATING INSOMNIA, COMBINING EMERGING SCIENCE, TECHNOLOGY AND SUPPORT
Ebb Therapeutics is revolutionizing sleep therapy with the first FDA-cleared drug-free approach to insomnia. FIVE and Ebb worked together to re-envision the patient journey and identify novel opportunities to improve patient engagement and adherence. As part of their work together, FIVE has conducted patient interviews and journey mapping workshops as well as provided strategic guidance and new service design and implementation support.
THE LINK BETWEEN MIND AND SLEEP
Ebb’s founder, Dr. Nofzinger, discovered through brain imaging studies that when the front of the brain shows a reduction in activity, the person falls into a restorative sleep. But people suffering from insomnia have an increase in front brain activity.
By having a window into the minds of patients seeking sleep, he was able to make a significant discovery that would eventually lead to a revolutionary sleep solution.
Armed with a clearer understanding of what’s happening in the brains of those suffering from insomnia, Dr. Nofzinger began his development of a drug-free solution that reduces brain activity and helps calm the mind by precisely cooling the forehead.
The opportunity to transform the lives of individuals experiencing insomnia has fueled the continuing development of the Ebb Insomnia Therapy.